Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
Breaking Updates in Hematological-Oncology
The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.ASH 2021
An insightful interview with @elenicelli (@Aristoteleio) on treatment options and risk management in patients with GvHD, the Young EHA committee & more!
Stay tuned for the full interview, which will be posted to http://VJHemOnc.com
@EHA_Hematology @young_eha #GvHD #HemOnc
@krikirschner highlights the impact of the DNA methylation clocks and EpiAge increases in #CHIP carriers and all cause mortality #EHA2023 #geriheme
Berend Snijder @BerendSnijder and Philipp Staber @PhilippStaber gave excellent talks on #functionalprecisionmedicine in hematology at #EHA2023. More clinical trials are coming up!
@TheSFPM
Prof El-Galaly: Simple epidemiology still adds value #lymsm #EHA2023
Great talk by @Stelegouill about Immunotherapy for R/R DLBCL !!!
✍️📚👨💻👨🏻⚕️
- monoclonal Abs
- Ab-Drug Conjugate
- CAR-T
- Bispecific
#EHA2023 #hematology
ASH 2021
Breaking Updates in Hematological-Oncology
The American Society of Hematology (ASH) 2021 Annual Meeting and Exposition was held in Atlanta on the 11-14 December. ASH has successfully honed the hybrid model and showcased outstanding leaps in understanding and treatment in 2021, across malignancies. Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.An insightful interview with @elenicelli (@Aristoteleio) on treatment options and risk management in patients with GvHD, the Young EHA committee & more!
Stay tuned for the full interview, which will be posted to http://VJHemOnc.com
@EHA_Hematology @young_eha #GvHD #HemOnc
@krikirschner highlights the impact of the DNA methylation clocks and EpiAge increases in #CHIP carriers and all cause mortality #EHA2023 #geriheme
Berend Snijder @BerendSnijder and Philipp Staber @PhilippStaber gave excellent talks on #functionalprecisionmedicine in hematology at #EHA2023. More clinical trials are coming up!
@TheSFPM
Prof El-Galaly: Simple epidemiology still adds value #lymsm #EHA2023
Great talk by @Stelegouill about Immunotherapy for R/R DLBCL !!!
✍️📚👨💻👨🏻⚕️
- monoclonal Abs
- Ab-Drug Conjugate
- CAR-T
- Bispecific
#EHA2023 #hematology
Popular videos
View all
Press Briefings
View all
Multiple Myeloma
View all
Lymphoma
View all
Acute Myeloid Leukemia
View all
Acute Lymphoblastic Leukemia
View all
Myelodysplastic Syndromes
View all
Chronic Lymphocytic Leukemia
View all
Myeloproliferative Neoplasms
View all
CAR-T & Cellular Therapy News
View all
Transplantation
View all
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
